TrialEuropean journal of clinical pharmacology2015

CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.

Paulo Roberto Xavier Tomaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.